The soluble EPCR (sEPCR) level at admission is positively correlated with CM and malaria-related mortality, and admission sEPCR was identified as an early biomarker of prognosis among CM patients (Ramos et al., 2013). This evidence concerns the gene PROCR and cutaneous mastocytosis.